Biopharmaceutical applications of group sequential designsHEARRON, A. E; ELFRING, G. L; SCHULTZ, J. R et al.Communications in statistics. Theory and methods. 1984, Vol 13, Num 19, pp 2419-2450, issn 0361-0926Article

Phase I and pharmacokinetic trial of oral irinotecan administered daily for 5 days every 3 weeks in patients with solid tumorsDRENGLER, R. L; KUHN, J. G; ELFRING, G. L et al.Journal of clinical oncology. 1999, Vol 17, Num 2, pp 685-696, issn 0732-183XArticle

Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeksROTHENBERG, M. L; KUHN, J. G; ELFRING, G. L et al.Annals of oncology. 2001, Vol 12, Num 11, pp 1631-1641, issn 0923-7534Article

Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancerROTHENBERG, M. L; ECKARDT, J. R; WEISS, G. R et al.Journal of clinical oncology. 1996, Vol 14, Num 4, pp 1128-1135, issn 0732-183XArticle

A multicenter, Phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinomaROTHENBERG, M. L; COX, J. V; MOHRLAND, J. S et al.Cancer. 1999, Vol 85, Num 4, pp 786-795, issn 0008-543XArticle

Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly irinotecan in patients with advanced solid tumorsSALTZ, L. B; SPRIGGS, D; SEMPLE, D et al.Journal of clinical oncology. 1998, Vol 16, Num 12, pp 3858-3865, issn 0732-183XArticle

Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosisWILSCHANSKI, M; MILLER, L. L; COHEN-CYMBERKNOH, M et al.The European respiratory journal. 2011, Vol 38, Num 1, pp 59-69, issn 0903-1936, 11 p.Article

Irinotecan therapy in adults with recurrent or progressive malignant gliomaFRIEDMAN, H. S; PETROS, W. P; CLOUGHSEY, T et al.Journal of clinical oncology. 1999, Vol 17, Num 5, pp 1516-1525, issn 0732-183XArticle

Phase II study of irinotecan plus cisplatin in patients with advanced non-small-cell lung cancerDEVORE, R. F; JOHNSON, D. H; MILLER, L. L et al.Journal of clinical oncology. 1999, Vol 17, Num 9, pp 2710-2720, issn 0732-183XArticle